BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16274557)

  • 1. An assessment of the first 3 years' use of Implanon in Luton.
    Agrawal A; Robinson C
    J Fam Plann Reprod Health Care; 2005 Oct; 31(4):310-2. PubMed ID: 16274557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.
    Lakha F; Glasier AF
    Contraception; 2006 Oct; 74(4):287-9. PubMed ID: 16982226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia.
    Nageso A; Gebretsadik A
    BMC Womens Health; 2018 Nov; 18(1):189. PubMed ID: 30453931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for requesting removal of the hormonal implant, Implanon NXT, at an urban reproductive health clinic in KwaZulu-Natal, South Africa.
    Beesham I; Smit J; Beksinska M; Panday M; Makatini V; Evans S
    S Afr Med J; 2019 Sep; 109(10):750-755. PubMed ID: 31635572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian women's experience with Implanon.
    Weisberg E; Fraser I
    Aust Fam Physician; 2005 Aug; 34(8):694-6. PubMed ID: 16113711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of implanon: two case reports.
    Evans R; Holman R; Lindsay E
    J Fam Plann Reprod Health Care; 2005 Jan; 31(1):71-2. PubMed ID: 15720859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removing deep Implanon implants.
    Bacon L
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):133; author reply 133. PubMed ID: 16824317
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness of a long-acting reversible contraceptive (Implanon) relative to oral contraception in a community setting.
    Lipetz C; Phillips CJ; Fleming CF
    Contraception; 2009 Apr; 79(4):304-9. PubMed ID: 19272500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
    Teunissen AM; Grimm B; Roumen FJ
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
    Mutihir JT; Daru PH
    Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the use of Implanon in three community services.
    Smith A; Reuter S
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):193-6. PubMed ID: 12419059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
    Beesham I; Smit J; Bosman SL; Milford C; Panday M; Beksinska M
    Afr J Reprod Health; 2021 Feb; 25(1):41-48. PubMed ID: 34077109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young women's knowledge, attitudes, and behaviors related to long-acting reversible contraceptives.
    Spies EL; Askelson NM; Gelman E; Losch M
    Womens Health Issues; 2010; 20(6):394-9. PubMed ID: 21050998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy.
    Lewis LN; Doherty DA; Hickey M; Skinner SR
    Contraception; 2010 May; 81(5):421-6. PubMed ID: 20399949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.